Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04416191 · ClinicalTrials.gov registry record · NA
Immune Cells During Disuse and Recovery
A NA study of Muscle Disuse, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT04416191: Recruiting NA study of Muscle Disuse, sponsored by University of Utah.
NCT04416191 is a NA study of Muscle Disuse that is actively recruiting participants, run by University of Utah. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04416191, a NA study of Muscle Disuse, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an interventional study enrolling healthy individuals aged 18-35 and 60-85 to understand the recovery of muscle health following a period of inactivity. The enrollment goal is 45 participants. The study will occur over the course of 1-2 months where participants will undergo testing before and after a 2-week limb immobilization period.
Primary Outcome
change in thigh muscle volume as determined by MRI
Conditions Studied
Interventions
- OTHER Limb immobilization
Study Locations (1)
Utah
- The University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2022-05-15 |
| Est. Completion | 2028-04-30 |
| Phase | NA |
What NCT04416191 shows while recruiting
NCT04416191 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Muscle Disuse appearing as the primary indexed condition, and to 1 intervention - of which Limb immobilization is the first listed.
NCT04416191 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT04416191 about?
NCT04416191 is a clinical study titled "Immune Cells During Disuse and Recovery". This is an interventional study enrolling healthy individuals aged 18-35 and 60-85 to understand the recovery of muscle health following a period of inactivity. The enrollment goal is 45 participants. The study will occur over the course of 1-2 months where participants will undergo testing before a...
What is the current status of trial NCT04416191?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2022-05-15. Estimated completion is 2028-04-30.
What conditions does trial NCT04416191 study?
This clinical trial studies the following conditions: Muscle Disuse.
What interventions are being tested in trial NCT04416191?
The interventions under investigation include: Limb immobilization (OTHER).
Who is sponsoring clinical trial NCT04416191?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04416191 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Disuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04416191's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI